Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine.
A new method developed at Cornell provides tools and methodologies to compress hundreds of terabytes of genomic data to gigabytes, once again enabling researchers to store datasets in local computers.
Health information technology systems promised increased efficiency and reduced costs, but new ILR School-led research suggests these benefits have been elusive.
Bacteria naturally present in the human intestine can transform cholesterol-derived bile acids into powerful metabolites that strengthen anticancer immunity by blocking androgen signaling, according to a preclinical study.
A group of 34 earned their short white coats as the newest class in Weill Cornell Medicine’s Master of Science in Health Sciences for Physician Assistants program.
An FDA-approved drug used in humans has been found to inhibit the growth of oral squamous cell carcinomas in dogs - with one dog’s tumor nearly disappearing in a matter of weeks.
The resulting atlas advances basic research on the biology of the pancreas and could lead to new treatment strategies for diabetes and other pancreatic diseases.